We provide you with 20 years of free, institutional-grade data for TARS stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of TARS. Explore the full financial landscape of TARS stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$2,447,845
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Azamian Bobak R. | Sale | -10,000 | $61.24 | $612,400 | 2026-06-22 |
| Goodrich Katherine | Sale | -2,954 | $62.08 | $183,384 | 2026-06-17 |
| LINK WILLIAM J PHD | Sale | -12,500 | $61.97 | $774,625 | 2026-06-17 |
| Farrow Jeffrey S | Sale | -14,396 | $60.95 | $877,436 | 2026-06-17 |
| Farrow Jeffrey S | Derivatives Exercise | 27,881 | 2026-06-17 | ||
| Morrison Scott W | Derivatives Exercise | 2,954 | 2026-06-16 | ||
| LINK WILLIAM J PHD | Derivatives Exercise | 2,954 | 2026-06-16 | ||
| CHAUDHURI BHASKAR | Derivatives Exercise | 2,954 | 2026-06-16 | ||
| Goodrich Katherine | Derivatives Exercise | 2,954 | 2026-06-16 | ||
| YARNO WENDY L | Derivatives Exercise | 2,954 | 2026-06-16 | ||
| Goldberg Andrew D. | Derivatives Exercise | 2,954 | 2026-06-16 | ||
| PYOTT DAVID E I | Derivatives Exercise | 1,383 | 2026-04-28 | ||
| Neervannan Seshadri | Sale | -2,989 | $66.75 | $199,516 | 2026-03-24 |
| Whitfield Dianne C. | Sale | -12,274 | $69.42 | $852,061 | 2026-03-19 |
| Wahl Bryan | Sale | -12,440 | $69.42 | $863,585 | 2026-03-19 |
| Neervannan Seshadri | Sale | -11,324 | $69.42 | $786,112 | 2026-03-19 |
| Mottiwala Aziz | Sale | -13,056 | $69.42 | $906,348 | 2026-03-19 |
| Lin Elizabeth Yeu | Sale | -1,144 | $69.42 | $79,416 | 2026-03-19 |
| Farrow Jeffrey S | Sale | -6,430 | $69.42 | $446,371 | 2026-03-19 |
| Azamian Bobak R. | Sale | -34,603 | $69.42 | $2,402,140 | 2026-03-19 |
| Whitfield Dianne C. | Sale | -15,565 | $80.09 | $1,246,601 | 2026-01-06 |
| Azamian Bobak R. | Sale | -6,000 | $82.41 | $494,460 | 2025-12-30 |
| Whitfield Dianne C. | Sale | -7,397 | $80.1 | $592,500 | 2025-12-18 |
| Lin Elizabeth Yeu | Sale | -2,078 | $79.5 | $165,201 | 2025-12-17 |
| Lin Elizabeth Yeu | Derivatives Exercise | 6,819 | 2025-12-17 | ||
| LINK WILLIAM J PHD | Sale | -10,446 | $80.71 | $843,097 | 2025-12-17 |
| LINK WILLIAM J PHD | Sale | -12,500 | $80.8 | $1,010,000 | 2025-12-17 |
| Azamian Bobak R. | Sale | -6,000 | $55.37 | $332,220 | 2025-09-26 |
| Morrison Scott W | Derivatives Exercise | 1,334 | 2025-09-16 | ||
| LINK WILLIAM J PHD | Sale | -27,116 | $57 | $1,545,612 | 2025-09-10 |
| Azamian Bobak R. | Sale | -6,000 | $50 | $300,000 | 2025-08-13 |
| Farrow Jeffrey S | Sale | -13,608 | $40.42 | $550,035 | 2025-06-18 |
| Farrow Jeffrey S | Derivatives Exercise | 27,881 | 2025-06-18 | ||
| Lin Elizabeth Yeu | Sale | -1,006 | $41.08 | $41,326 | 2025-06-17 |
| Lin Elizabeth Yeu | Derivatives Exercise | 3,350 | 2025-06-17 | ||
| Goldberg Andrew D. | Derivatives Exercise | 3,350 | 2025-06-16 | ||
| CHAUDHURI BHASKAR | Derivatives Exercise | 3,350 | 2025-06-16 | ||
| LINK WILLIAM J PHD | Derivatives Exercise | 3,350 | 2025-06-16 | ||
| YARNO WENDY L | Derivatives Exercise | 3,350 | 2025-06-16 | ||
| Morrison Scott W | Derivatives Exercise | 3,350 | 2025-06-16 | ||
| Mottiwala Aziz | Sale | -17,500 | $43.76 | $765,800 | 2025-06-11 |
| Azamian Bobak R. | Sale | -6,000 | $50 | $300,000 | 2025-03-26 |
| Azamian Bobak R. | Sale | -24,216 | $46.29 | $1,120,959 | 2025-03-20 |
| Farrow Jeffrey S | Sale | -3,724 | $46.29 | $172,384 | 2025-03-20 |
| Wahl Bryan | Sale | -9,686 | $46.29 | $448,365 | 2025-03-20 |
| Mottiwala Aziz | Sale | -10,565 | $46.29 | $489,054 | 2025-03-20 |
| Whitfield Dianne C. | Sale | -6,711 | $46.29 | $310,652 | 2025-03-20 |
| Neervannan Seshadri | Sale | -7,583 | $46.29 | $351,017 | 2025-03-20 |
| Farrow Jeffrey S | Derivatives Exercise | 8,019 | 2025-03-18 | ||
| Azamian Bobak R. | Derivatives Exercise | 51,395 | 2025-03-18 | ||
| Whitfield Dianne C. | Derivatives Exercise | 18,885 | 2025-03-18 | ||
| Wahl Bryan | Derivatives Exercise | 19,213 | 2025-03-18 | ||
| Neervannan Seshadri | Derivatives Exercise | 21,264 | 2025-03-18 | ||
| Mottiwala Aziz | Derivatives Exercise | 20,957 | 2025-03-18 | ||
| Goldberg Andrew D. | Derivatives Exercise | 7,000 | 2025-03-11 | ||
| Morrison Scott W | Derivatives Exercise | 1,333 | 2024-09-17 | ||
| LINK WILLIAM J PHD | Sale | -35,000 | $26.01 | $910,350 | 2024-08-14 |
| Lin Elizabeth Yeu | Derivatives Exercise | 3,350 | 2024-06-25 | ||
| Crane Rosemary A | Derivatives Exercise | 3,350 | 2024-06-25 | ||
| LINK WILLIAM J PHD | Derivatives Exercise | 3,350 | 2024-06-25 | ||
| Goldberg Andrew D. | Derivatives Exercise | 3,350 | 2024-06-25 |
The information provided in this report about TARS stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Tarsus Pharmaceuticals, Inc(NASDAQ:TARS) 
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase IIb/III for the treatment of blepharitis cau...
Website: http://www.tarsusrx.com
Founded: 2016
Full Time Employees: 18
CEO / Co-Founder: Bobak Azamian
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends